Moderna exits gene editing deal worth up to $3B biobucks, leaving Metagenomi in the spotlight

Earlier this year, Metagenomi had the spotlight with a $93.7 million IPO. Now, Moderna is exiting stage left on a partnership worth up to $3 billion in biobucks.